LOX-1 and ROS, inseparable factors in the process of endothelial damage

Free Radical Research

Volumn 48, Issue 8, 2014, Pages 841-848

  Lubrano, V ^a   Balzan, S ^a  

^a CNR   (Italy)

Author keywords

Angiogenesis; Endothelial function; Free radicals; Ox LDL receptors; Oxidative stress

Indexed keywords

ANGIOTENSIN II; C REACTIVE PROTEIN; ENDOTHELIN 1; FREE RADICAL; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; LOW DENSITY LIPOPROTEIN; OLR1 PROTEIN, HUMAN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANGIOGENESIS; APOPTOSIS; ATHEROSCLEROSIS; BINDING SITE; BRAIN INFARCTION; CAPILLARY TUBE; CELL ACTIVATION; CELL DAMAGE; CELL DEATH; CELL MOTILITY; CELL SURVIVAL; DIABETES MELLITUS; DIET; DOWN REGULATION; ENDOCYTOSIS; ENDOTHELIAL DYSFUNCTION; GENE OVEREXPRESSION; HEART INFARCTION; HUMAN; HYPERTENSION; INTERNALIZATION; LIPID DIET; LIPID PEROXIDATION; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; OXIDATIVE STRESS; POSITIVE FEEDBACK; PROMOTER REGION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY; REVIEW; SHEAR STRESS; SMOKING; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; ANIMAL; DRUG EFFECTS; ENDOTHELIUM CELL; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ENDOTHELIAL CELLS; FREE RADICALS; HUMANS; LIPOPROTEINS, LDL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SCAVENGER RECEPTORS, CLASS E; SIGNAL TRANSDUCTION;

EID: 84903958619     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2014.929122     Document Type: Review

References (74)

1. Suzuki T, Kohno H, Hasegawa A, Toshima S, Amaki T, Kurabayashi M, et al. Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease. Clin Biochem 2002; 35:347-353.
2. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997; 386:73-77.
3. Twigg MW, Freestone K, Homer-Vanniasinkam S, Ponnambalam S. The LOX-1 scavenger receptor and its implications in the treatment of vascular disease. Cardiol Res Pract 2012; 2012:632408.
4. Goyal T, Mitra S, Khaidakov M, Wang X, Singla S, Ding Z, et al. Current concepts of the role of oxidized LDL receptors in atherosclerosis. Curr Atheroscler Rep 2012; 14:150-159.
5. Murase T, Kume N, Korenaga R, Ando J, Sawamura T, Masaki T, Kita T. Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 1998; 83:328-333.
6. Lubrano V and Balzan S. LOX-1, a new marker of risk and prognosis in coronary artery disease? Mol Cell Biochem 2013; 383:223-230.
7. Jono T, Miyazaki A, Nagai R, Sawamura T, Kitamura T, Horiuchi S. Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Lett 2002; 511:170-174.
8. Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G. Lectinlike, oxidized low-density lipoprotein receptor-1 (LOX-1):a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 2006; 69:36-45.
9. Kataoka H, Kume N, Miyamoto S, Minami M, Moriwaki H, Murase T, et al. Expression of lectin-like oxidized low density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 1999; 99:3110-3117.
10. Kita T, Kume N, Minami M, Hayashida K, Murayama T, Sano H, et al. Role of oxidized LDL in atherosclerosis. Ann N Y Acad Sci. 2001; 947:199-205.
11. Cominacini L, Fratta Pasini A, Garbin U, Pastorino A, Rigoni A, Nava C, et al. The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells. J Am Coll Cardiol 2003; 41:499-507.
12. Xu S, Ogura S, Chen J, Little PJ, Moss J and Liu P. LOX-1 in atherosclerosis:biological functions and pharmacological modifiers. Cell Mol Life Sci 2013; 70:2859-2872.
13. Moriwaki H, Kume N, Sawamura T, Aoyama T, Hoshikawa H, Ochi H, et al. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol 1998; 18:1541-1547.
14. Pirillo A, Norata GD, Catapano AL. LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm 2013; 2013:1-12. doi:10.1155/2013/152786.
15. Chen J, Liu Y, Liu H, Hermonat PL, Mehta JL. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells:implications for atherosclerosis. Biochem J 2006; 393:255-265.
16. Chen J, Liu Y, Liu H, Hermonat PL, Mehta JL. Molecular dissection of angiotensin II-activated human LOX-1 promoter. Arterioscler Thromb Vasc Biol 2006; 26:1163-1168.
17. Coles AH, Gannon H, Cerny A, Kurt-Jones E, Jones SN. Inhibitor of growth-4 promotes IkappaB promoter activation to suppress NF-kappaB signaling and innate immunity. Proc Natl Acad Sci U S A. 2010; 107:11423-11428.
18. Kashiwase K, Higuchi Y, Hirotani S, Yamaguchi O, Hikoso S, Takeda T, et al. CaMKII activates ASK1 and NF-kappaB to induce cardiomyocyte hypertrophy. Biochem Biophys Res Commun 2005; 327:136-142.
19. Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 2000; 275:12633-12638.
20. Groeger G, Quiney C, Cotter TG. Hydrogen peroxide as a cell-survival signaling molecule. Antioxid Redox Signal 2009; 11:2655-2671.
21. Dandapat A, Hu C, Sun L, Mehta JL. Small concentrations of ox-LDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arterioscler Thromb Vasc Biol 2007; 27:2435-2442.
22. Kamata H, Manabe T, Oka S, Kamata K, Hirata H. Hydrogen peroxide activate IkappaB kinases through phosphorylation of serine residues in the activation loops. FEBS Lett 2002; 519:231-237.
23. Anilkumar N, Weber R, Zhang M, Brewer A, Shah AM. NOX4 and NOX2 NADPH oxidases mediate distinct cellular redox signaling response to agonist stimulation. Arterioscler Thromb Vasc Biol 2007; 27:2435-2442.
24. Cominacini L, Rigoni A, Pasini AF, Garbin U, Davoli A, Campagnola M, Pastorino AM, et al. The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem 2001; 276:13750-13755.
25. Mehta JL, Li DY. Identification and autoregulation of receptor for ox-LDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun 1998; 248:511-514.
26. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, et al. HMEC-1:establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992; 99:683-690.
27. Abarquez RF. Microvascular disease relevance in the hypertension syndrome. Clin Hemorheol Microcirc 2003; 29:295-300.
28. He Z, King GL. Microvascular complications of diabetes. Endocrinol Metab Clin North Am 2004; 33:215-238.
29. Stokes K, Cooper D, Tailor A, Granger DN. Hypercholesterolemia promotes inflammation and microvascular dysfunction:role of nitric oxide and superoxide. Free Radic Biol Med 2002; 33:1026-1036.
30. Lubrano V, Del Turco S, Nicolini G, Di Cecco P, Basta G. Circulating levels of lectin-like oxidized low-density lipoprotein receptor-1 are associated with inflammatory markers. Lipids 2008; 43:945-950.
31. Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Ann Rev Pharmacol. Toxicol 1990; 30:535-560.
32. Huie RE, Padmaja S. The reaction of no with superoxide. Free Radic Res Commun 1993; 18:195-199.
33. Chen XP, Xun KL, Wu Q, Zhang TT, Shi JS, Du GH. Oxidized low density lipoprotein receptor-1 mediates oxidized low density lipoprotein induced apoptosis in human umbilical vein endothelial cells:role of reactive oxygen species. Vasc Pharmacol 2007; 47:1-9.
34. Li JM, Shah AM. Endothelial cell superoxide generation:regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 2004; 287:R1014-R1030.
35. Mehta JL, Chen J, Yu F, Li DY. Aspirin inhibits ox-LDLmediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells. Cardiovasc Res 2004; 64:243-249.
36. Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 2012; 32:2045-2051.
37. Hansson GK, Robertson AK, Soderberg-Naucler C. Inflammation and atherosclerosis. Ann Rev Pathol 2006; 1:297-329.
38. Lu J, Mitra S, Wang X, Khaidakov M, Mehta JL. Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis. Antiox Redox Signal 2011; 15:2301-2333.
39. Holvoet P, Harris TB, Tracy RP, Verhamme P, Newman AB, Rubin SM, et al. Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly:findings from the Health, Aging, and Body Composition study. Arterioscler Thromb Vasc Biol 2003; 23:1444-1448.
40. Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, et al. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. Diabetes 2004; 53:1068-1073.
41. Segev A, Strauss BH, Witztum JL, Lau HK, Tsimikas S. Relationship of a comprehensive panel of plasma oxidized lowdensity lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina. Am Heart J 2005; 150:1007-1014.
42. Li R, Mittelstein D, Fang K, Beebe T, Quigley K, Berliner J, Hsiai TK. Angiopoeitin-2 modulates Survivin expression in OxLDL-induced endothelial cell apoptosis. Biochem Biophys Res Commun 2011; 417:619-622.
43. Mattaliano MD, Huard C, Cao W, Hill AA, Zhong W, Martinez RV, et al. LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells. Am J Physiol Cell Physiol 2 011; 96:C1329-C1337.
44. Salvayre R, Auge N, Benoist H, Negre-Salvayre A. Oxidized low-density lipoprotein-induced apoptosis. Biochem Biophys Acta 2002; 30:213-221.
45. Kataoka H, Kume N, Miyamoto S, Minami M, Morimoto M, Hayashida K, et al. Oxidized LDL Modulates Bax/Bcl-2 Through the Lectinlike Ox-LDL Receptor-1 in Vascular Smooth Muscle Cells. Arterioscler Thromb Vasc Biol 2001; 21:955-960.
46. Wu CY, Tang ZH, Jiang L, Li XF, Jiang ZS, Liu LS. PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax - caspase9 - caspase3 pathway. Mol Cell Biochem 2012; 359:347-358.
47. Rueckschloss U, Villmow M, Klöckner U. NADPH oxidasederived superoxide impairs calcium transients and contraction in aged murine ventricular myocytes. Exp Gerontol 2010; 45:788-796.
48. Ou HC, Song TY, Yeh YC, Huang CY, Yang SF, Chiu TH, et al. EGCG protects against oxidized LDL-induced endothelial dysfunction by inhibiting LOX-1-mediated signaling. J Appl Physiol (1985). 2010; 108:1745-1756.
49. Khaidakov M, Mitra S, Wang X, Ding Z, Bora N, Lyzogubov V, et al. Large impact of low concentration oxidized LDL on angiogenic potential of human endothelial cells:a microarray study. PLoS One 2012; 7:e47421.
50. Wu FT, Stefanini MO, Mac Gabhann F, Kontos CD, Annex BH, Popel AS. A systems biology perspective on sVEGFR1:its biological function, pathogenic role and therapeutic use. J Cell Mol Med. 2010; 14:528-552.
51. Moulton KS. Angiogenesis in atherosclerosis:gathering evidence beyond speculation. Curr Opin Lipidol. 2006; 17:548-555.
52. Li D, Mehta JL. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells:evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol 2000; 20:1116-1122.
53. Hsieh HJ, Cheng CC, Wu ST, Chiu JJ, Wung BS, Wang DL. Increase of reactive oxygen species (ROS) in endothelial cells by shear flow and involvement of ROS in shear-induced c-fos expression. J Cell Physiol 1998; 175:156-162.
54. Bolli R, Zughaib M, Li XY, Tang XL, Sun JZ, Triana JF, McCay PB. Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function. A pathophysiological basis for chronic myocardial "Stunning". J Clin Invest 1995; 96:1066-1084.
55. Li D, Liu L, Chen H, Sawamura T, Mehta JL. LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 2003; 23:816-821.
56. Koga K, Kenessey A, Powell S, Sison CP, Miller EJ, Ojamaa K. Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress. Antioxid Redox Signal 2011; 14:1191-1202.
57. Li D, Williams V, Liu L, Chen H, Sawamura T, Romeo F, Mehta JL. Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol 2003; 41:1048-1055.
58. Nagase M, Kaname S, Nagase T, Wang G, Ando K, Sawamura T, Fujita T. Expression of LOX-1, an oxidized lowdensity lipoprotein receptor, in experimental hypertensive glomerulo-sclerosis. J Am Soc Nephrol 2000; 11:1826-1836.
59. Li D, Saldeen T, Romeo F, Mehta JL. Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells:the potential role of transcription factor NF-kappaB. Circulation 2000; 102:1970-1976.
60. Morawietz H, Rueckschloss U, Niemann B, Duerrschmidt N, Galle J, Hakim K, et al. Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation 1999; 100:899-902.
61. Hu C, Dandapat A, Sun L, Marwali MR, Inoue N, Sugawara F, et al. Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion. Hypertension 2008; 52:556-562.
62. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342:821-828.
63. Kobayashi N, Honda T, Yoshida K, Nakano S, Ohno T, Tsubokou Y, Matsuoka H. Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition. Atherosclerosis 2006; 187:92-100.
64. Aoki M, Nata T, Morishita R, Matsushita H, Nakagami H, Yamamoto K, et al. Endothelial apoptosis induced by oxidative stress through activation of NFkB:antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension. 2001; 38:48-55.
65. Rossig L, Hoffmann J, Hugel B, Mallat Z, Haase A, Freyssinet JM, et al. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation. 2001; 104:2182-2187.
66. Kris-Etherton PM, Keen CL. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol. 2002; 13:41-49.
67. Dugas AJ, Castaneda-Acosta J, Bonin GC, Price KL, Fischer NH, Winston GW. Evaluation of the total peroxyl radicalscavenging capacity of flavonoids:structure-activity relationships. J Nat Prod. 2000; 63:327-331.
68. Ou HC, Chou FP, Sheen HM, Lin TM, Yang CH, Huey-Herng Sheu W. Resveratrol, a polyphenolic compound in red wine, protects against oxidized LDL-induced cytotoxicity in endothelial cells. Clin Chem Acta. 2006; 364:196-204.
69. Zafarullah M, Li WQ, Sylvester J, Ahmad M. Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 2003; 60:6-20.
70. Lubrano V, Baldi S, Napoli D, Longo V. Beneficial effect of Lisosan G on cultured human microvascular endothelial cells exposed to oxidised low density lipoprotein. Indian J Med Res 2012; 136:82-88.
71. Takanabe-Mori R, Ono K, Sowa N, Wada H, Takaya T, Horie T, et al. Lectin-like oxidized low-density lipoprotein receptor- 1 is required for the adipose tissue expression of proinflammatory cytokines in high-fat diet-induced obese mice. Biochem Biophys Res Commun. 2010; 398:576-80.
72. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease:an update. J Am Coll Cardiol 2004; 43:1731-1737.
73. Uchida K, Suehiro A, Nakanishi M, Sawamura T, Wakabayashi I. Associations of atherosclerotic risk factors with oxidized low-density lipoprotein evaluated by LOX-1 ligand activity in healthy men. Clin Chem Acta. 2011; 412:1643-1647.
74. Brinkley TE, Kume N, Mitsuoka H, Phares DA, Hagberg JM. Elevated soluble lectin-like oxidized LDL receptor-1 (sLOX-1) levels in obese postmenopausal women. Obesity 2008; 16:1454-1456.